NCT03980340

Brief Summary

Insufficient sleep has both health and safety risks, but currently there are no quick, accurate and inexpensive ways to measure sleep deficiency. The current study aims to use a cutting-edge technology, small molecule analysis (e.g. metabolomics), to detect compounds in breath that reliably change with sleep-wake state and those whose levels vary by time of day.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
5

participants targeted

Target at below P25 for all trials

Timeline
Completed

Started Jan 2021

Longer than P75 for all trials

Geographic Reach
1 country

1 active site

Status
terminated

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

May 23, 2019

Completed
18 days until next milestone

First Posted

Study publicly available on registry

June 10, 2019

Completed
1.6 years until next milestone

Study Start

First participant enrolled

January 28, 2021

Completed
4 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 31, 2025

Completed
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

March 31, 2025

Completed
Last Updated

August 3, 2025

Status Verified

July 1, 2025

Enrollment Period

4 years

First QC Date

May 23, 2019

Last Update Submit

July 30, 2025

Conditions

Keywords

SleepCircadian RhythmsCircadian Rhythm Disorder

Outcome Measures

Primary Outcomes (3)

  • Comparison of the change in composition of chemical analytes from the breath test

    The change in composition of chemical analytes from the breath analysis tests will be compared between the Short Nap Intervention and No Nap Intervention groups to see if there is a sleep-related change in the components of breath.

    Study day 1

  • Change in composition of chemical analytes from the breath test

    The analytes present in individual subject's breath samples before and after a short nap (in the Short Nap Intervention) will be analyzed for differences in chemical composition.

    Study day 1

  • Circadian differences in composition of chemical analytes from the breath test

    The analytes present in breath samples after a short nap (in the Short Nap Intervention) will be analyzed for differences in chemical composition depending on time of day (circadian variation).

    Study day 1

Interventions

Study participants may be asked to have a 1-2 hour nap in between the breath analysis tests.

Study participants may be asked to sit or lay down remaining awake for 1-2 hours in between breath analysis tests.

Eligibility Criteria

Age18 Years - 50 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64)
Sampling MethodNon-Probability Sample
Study Population

Healthy volunteers will be recruited from the surrounding community.

You may qualify if:

  • Healthy Adults who are able to fall asleep in the study conditions
  • Beginning 2 hours before the study, participants will be asked to refrain from brushing their teeth, using mouthwash, eating or drinking anything (other than water), chewing gum, smoking, etc., until the study is complete.

You may not qualify if:

  • Individuals on special diets (such as a very low carbohydrate diet) may be excluded
  • Acute or debilitating medical condition
  • Recent history of dental problems (gum disease, abcess, surgery) or current dental or mouth pain
  • Current use of stimulants, hypnotics, tranquilizers, Central Nervous System active substances, and/or antibiotics.
  • Use of products containing nicotine 24 hours prior to study

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Brigham and Women's Hospital

Boston, Massachusetts, 02115, United States

Location

Biospecimen

Retention: SAMPLES WITHOUT DNA

Saliva samples may be collected and assayed for cortisol.

MeSH Terms

Conditions

Sleep Disorders, Circadian RhythmSleep Disorders, IntrinsicChronobiology Disorders

Condition Hierarchy (Ancestors)

Nervous System DiseasesDyssomniasSleep Wake DisordersOccupational DiseasesMental Disorders

Study Officials

  • Jeanne F Duffy, MBA, PhD

    Brigham and Women's Hospital

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
OTHER
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

May 23, 2019

First Posted

June 10, 2019

Study Start

January 28, 2021

Primary Completion

January 31, 2025

Study Completion

March 31, 2025

Last Updated

August 3, 2025

Record last verified: 2025-07

Locations